4.5 Review

Imaging Techniques: Options for the Diagnosis and Monitoring of Treatment of Enthesitis in Psoriatic Arthritis

Journal

JOURNAL OF RHEUMATOLOGY
Volume 47, Issue 7, Pages 973-982

Publisher

J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.190512

Keywords

PSORIATIC ARTHRITIS; MAGNETIC RESONANCE IMAGING; ULTRASONOGRAPHY; OUTCOME ASSESSMENT; DIAGNOSTIC IMAGING

Categories

Funding

  1. Novartis Pharmaceuticals Corp.

Ask authors/readers for more resources

Psoriatic arthritis (PsA) affects up to 30% of patients with psoriasis and may include musculoskeletal manifestations such as enthesitis. Enthesitis is associated with joint damage, and early detection and treatment are essential to management of the disease. Traditionally assessed by clinical examination and conventional radiography, entheseal inflammation can now be more accurately assessed earlier in the disease using techniques such as ultrasound, magnetic resonance imaging, computed tomography, and molecular imaging. However, there is little consensus on the optimum definition for diagnosing enthesitis in PsA or on the ideal scoring system for measuring response to treatment. This review aims to summarize the benefits and limitations of different imaging modalities in the assessment of enthesitis. It also proposes that adoption of standardized definitions and validation of scoring systems and imaging techniques in clinical trials will allow the efficacy of new treatment options to be assessed more accurately.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Incidence of and Risk Factors for Heart Failure in Patients With Psoriatic Disease: A Cohort Study

Sahil Koppikar, Keith Colaco, Paula Harvey, Shadi Akhtari, Vinod Chandran, Dafna D. Gladman, Richard Cook, Lihi Eder

Summary: This study aimed to assess the incidence and risk factors for heart failure in patients with psoriatic disease and describe their electrocardiographic and echocardiographic findings. The results showed that heart failure was associated with a combination of known cardiovascular risk factors and measures of disease activity, particularly in nonischemic heart failure.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

Comparative Efficacy of Different Triage Methods for Psoriatic Arthritis: Results From a Prospective Study in a Rapid Access Clinic

Samantha Sarabia, Chandra Farrer, Jensen Yeung, Dana Jerome, Richard J. Cook, Lihi Eder

Summary: Combining MSK-US with a screening questionnaire improves the triage of patients with suspected PsA.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing

Lihi Eder, Ruth Croxford, Aaron M. Drucker, Arielle Mendel, Bindee Kuriya, Zahi Touma, Sindhu R. Johnson, Richard Cook, Sasha Bernatsky, Nigil Haroon, Jessica Widdifield

Summary: Compared with the general population, patients with immune-mediated inflammatory diseases (IMIDs) were more likely to be tested for SARS-CoV-2, but the infection rate was similar. The odds of SARS-CoV-2 infection varied across different IMID subgroups.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis

Jessica Widdifield, Lihi Eder, Simon Chen, Jeffrey C. Kwong, Carol Hitchon, Diane Lacaille, J. Antonio Avina-Zubieta, Lawrence W. Svenson, Sasha Bernatsky

Summary: This study assessed the uptake of COVID-19 vaccines among individuals with immune-mediated inflammatory diseases (IMIDs) and the general population in Ontario. The results showed that IMID patients had higher vaccination rates compared to the general population, particularly among those with stronger immune responses.

JOURNAL OF RHEUMATOLOGY (2022)

Article Rheumatology

Improved outcomes in rheumatoid arthritis with obesity after a weight loss intervention: randomized trial

Veena K. Ranganath, Antonio La Cava, Sitaram Vangala, Jenny Brook, Tanaz A. Kermani, Daniel E. Furst, Mihaela Taylor, Gurjit S. Kaeley, Catherine Carpenter, David A. Elashoff, Zhaoping Li

Summary: A weight loss intervention programme can help obese rheumatoid arthritis (RA) patients achieve weight loss and improve their clinical disease activity and ultrasound synovitis measures. However, further studies are needed to validate these findings and improve the clinical management of obese RA patients.

RHEUMATOLOGY (2023)

Article Rheumatology

Understanding sex-related differences in healthcare utilisation among patients with inflammatory arthritis: a population-based study

Sanjana Tarannum, Jessica Widdifield, C. Fangyun Wu, Sindhu R. Johnson, Paula Rochon, Lihi Eder

Summary: This study compared patterns of healthcare utilization between male and female patients with inflammatory arthritis (IA). The findings showed that female patients had higher healthcare utilization than male patients before and after diagnosis, possibly indicating biological differences in disease course or sociocultural differences in healthcare-seeking behavior.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Review Rheumatology

Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Lihi Eder, Ashish J. Mathew, Philippe Carron, Heidi Bertheussen, Juan D. Canete, May Azem, Andrea Delle Sedie, Carlo Salvarani, Roberto Ranza, Ashley Elliott, Anthony Turkiewicz, Ricardo Acayaba de Toledo, Hulya Bukulmez, Maria S. Stoenoiu, Arthur M. Mandelin II, Michaela Koehm, Chris A. Lindsay, Evan Siegel, Philip J. Mease

Summary: This article summarizes existing evidence regarding pharmaceutical and nonpharmaceutical interventions for enthesitis in patients with psoriatic arthritis (PsA) to facilitate an evidence-based update of the Group for Research and Assessment in Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for PsA. The article found several classes of systemic conventional and advanced therapies and local measures were recommended for active enthesitis in patients with PsA.

JOURNAL OF RHEUMATOLOGY (2023)

Article Rheumatology

Changes in Service Delivery and Access to Rheumatologists Before and During the COVID-19 Pandemic in a Canadian Universal Healthcare Setting

Timothy S. H. Kwok, Bindee Kuriya, Lauren K. King, Lihi Eder, J. Carter Thorne, Zhiyin Li, Therese Stukel, Longdi Fu, Alexander Kopp, Jessica Widdifield

Summary: This study described the changes in service delivery and access to rheumatologists during the COVID-19 pandemic in Ontario, Canada. The study found a significant decrease in outpatient office visits and a rise in telemedicine visits. There was also a decrease in new patient consultations over time, raising concerns for potential delays to diagnosis.

JOURNAL OF RHEUMATOLOGY (2023)

Article Rheumatology

The Effects of Continuity of Rheumatology Care on Emergency Department Utilization and Hospitalizations for Individuals With Early Rheumatoid Arthritis: A Population-Based Study

Abel Davtyan, Jennifer J. Y. Lee, Lihi Eder, Gillian A. Hawker, Jin Luo, Claire E. H. Barber, J. Carter Thorne, Jessica Widdifield

Summary: A study found that continuity of rheumatology care influences rates of emergency department visits and hospitalizations in patients with rheumatoid arthritis (RA). Patients who received continuous rheumatology care during the first 5 years after diagnosis had lower rates of ED visits and hospitalizations compared to those who did not receive continuous care. This study provides evidence supporting the value of early and continuous rheumatology care for reducing hospitalizations and ED visits.

JOURNAL OF RHEUMATOLOGY (2023)

Article Rheumatology

Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study

Gurjit S. Kaeley, Georg Schett, Philip G. Conaghan, Dennis McGonagle, Frank Behrens, Philippe Goupille, Corine Gaillez, Bhumik Parikh, Catherine Bakewell

Summary: This study evaluated the treatment response of enthesitis in PsA patients treated with secukinumab or adalimumab for 52 weeks. The results showed that both drugs had similar efficacy in resolving enthesitis, including time to resolution. The authors concluded that inhibition of IL-17 with secukinumab reduced clinical enthesitis similarly to TNF-alpha inhibition with adalimumab.

RHEUMATOLOGY (2023)

Article Rheumatology

Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension

Lihi Eder, Dafna D. Gladman, Philip Mease, Remy A. Pollock, Rayana Luna, Sibel Z. Aydin, Alexis Ogdie, Ari Polachek, David Gruben, Mary Jane Cadatal, Cassandra Kinch, Vibeke Strand

Summary: This study evaluated the impact of sex on the efficacy, safety, and persistence of tofacitinib in patients with psoriatic arthritis. The results showed that tofacitinib significantly improved disease symptoms in both male and female patients, with comparable efficacy. However, females had a slightly lower achievement rate of optimal disease control compared to males. There were no significant differences in safety and treatment persistence between sexes.

RMD OPEN (2023)

Article Rheumatology

Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards Prevention

Lihi Eder, Ker-Ai Lee, Vinod Chandran, Jessica Widdifield, Aaron M. Drucker, Christopher Ritchlin, Cheryl F. Rosen, Richard J. Cook, Dafna D. Gladman

Summary: The study aimed to develop a risk prediction model for psoriasis patients to predict their risk of developing psoriatic arthritis (PsA) and evaluate its performance. The results showed that using readily available clinical variables, the development of PsA within clinically meaningful time frames can be predicted with reasonable accuracy for psoriasis patients.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Derivation and Internal Validation of a Disease-Specific Cardiovascular Risk Prediction Model for Patients With Psoriatic Arthritis and Psoriasis

Keith Colaco, Ker-Ai Lee, Shadi Akhtari, Raz Winer, Vinod Chandran, Paula Harvey, Richard J. Cook, Vincent Piguet, Dafna D. Gladman, Lihi Eder

Summary: This study developed and validated a five-year disease-specific cardiovascular risk prediction model for patients with psoriatic disease (PsD). The results indicate that traditional cardiovascular risk factors alone are effective in predicting cardiovascular risk in PsD patients.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study

Ying Ying Leung, Lihi Eder, Ana-Maria Orbai, Laura C. Coates, Maarten de Wit, Josef S. Smolen, Uta Kiltz, Penelope Palominos, Juan D. Canete, Rossana Scrivo, Andra Balanescu, Emanuelle Dernis, Sandra Meisalu, Martin Soubrier, Umut Kalyoncu, Laure Gossec

RMD OPEN (2023)

Article Rheumatology

Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis

Christina Charles-Schoeman, Jennifer Wang, Ani Shahbazian, Holly Wilhalme, Jenny Brook, Gurjit S. Kaeley, Buzand Oganesian, Ami Ben-Artzi, David A. Elashoff, Veena K. Ranganath

Summary: Active rheumatoid arthritis (RA) is associated with increased cardiovascular risk and impaired function of high-density lipoprotein (HDL). The study evaluated the association between synovial power doppler ultrasound signal (PDUS) and HDL function and structure. Patients with higher baseline PDUS scores had worse HDL function, and treatment with tocilizumab or abatacept led to improvements in HDL function. These findings support previous research suggesting a direct link between joint inflammation and abnormal HDL function.

RHEUMATOLOGY INTERNATIONAL (2023)

No Data Available